Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2014-04-07 Annual Report
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
THR 14 05_FY 2013 resultsFinal _NL.pdf
Annual Report Classification · 95% confidence The document is a comprehensive business update and annual financial results report for ThromboGenics for the fiscal year 2013. It contains detailed financial data (revenue, net income, cash position), operational updates, management changes, and strategic outlooks. It is not a short announcement (it is over 60,000 characters) and provides substantive financial analysis, fitting the definition of an Interim/Quarterly or Annual Report. Given it covers the full year 2013 and includes financial statements/results, it is classified as an Annual Report (10-K equivalent for this jurisdiction). FY 2013
2014-04-07 Dutch
THR_13_25 Q3 Business Update FINAL.pdf
Management Reports Classification · 95% confidence The document is a 'Business Update' issued by ThromboGenics NV. It provides a narrative overview of commercial progress, product updates (JETREA), management changes, and market access developments. While it mentions a cash position, it lacks the formal financial statements, balance sheets, or income statements required for an Interim Report (IR). It is a qualitative management update on business operations and strategy, which fits the definition of a Management Report (MDA). 9M 2013
2013-11-20 English
TP clay2.pdf
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'PERSBERICHT' (Press Release) and discusses changes in shareholdings by related parties (Thomas Clay and Landon Clay) in Thrombogenics NV, referencing transparency notifications received. This directly relates to notifications about changes in significant share ownership crossing thresholds, which aligns with the definition for Major Shareholding Notification (MRQ). The document is short and serves as an announcement of the event rather than the official regulatory filing itself, but MRQ is the most specific category for this content type.
2013-09-20 Dutch
TP Clay.pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'PERSBERICHT' (Press Release) published under regulations concerning the disclosure of significant shareholdings ('openbaarmaking van belangrijke deelnemingen'). It explicitly details the holdings of specific shareholder groups (the Clay family) and confirms their consolidated position remains unchanged. This directly relates to changes or notifications regarding significant ownership thresholds. This aligns perfectly with the definition for Major Shareholding Notification (MRQ). The document is short and is a notification itself, not a comprehensive report.
2013-09-17 Dutch
TG GLOBAL - Financial report 30-06-2013 (EN).pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Financial Report Half-year results as of June 30, 2013'. It contains consolidated financial statements (statement of financial position and statement of comprehensive income) and detailed business highlights. It is a comprehensive report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2013
2013-08-30 English
TG GLOBAL - Financieel verslag 30-06-2013 (NL).pdf
Interim / Quarterly Report Classification · 100% confidence The document is a 'Tussentijds Financieel Verslag' (Interim Financial Report) for the period ending June 30, 2013. It contains detailed consolidated balance sheets, profit and loss statements, and extensive management discussion regarding business highlights, product pipelines (JETREA), and financial performance. Since it provides substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2013
2013-08-30 Dutch

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.